Page last updated: 2024-11-07

dehydroepiandrosterone and Urinary Bladder, Overactive

dehydroepiandrosterone has been researched along with Urinary Bladder, Overactive in 1 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Matarazzo, MG1
Sarpietro, G1
Fiorito, D1
Di Pasqua, S1
Ingrassano, S1
Panella, MM1
Cianci, A1
Caruso, S1

Other Studies

1 other study available for dehydroepiandrosterone and Urinary Bladder, Overactive

ArticleYear
Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study.
    European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 263

    Topics: Administration, Intravaginal; Atrophy; Dehydroepiandrosterone; Female; Humans; Pilot Projects; Postm

2021